Navigation Links
Scientists identify FLT3 gene as a valid therapeutic target in acute myeloid leukemia
Date:4/15/2012

is also Co-Director of the Institute for Genomics and Multiscale Biology at Mount Sinai. "Furthermore, if we can find out when the drug resistant mutations occur exactly, clinicians may be able to prescribe another drug more quickly."

In this era of personalized medicine, many drugs have been developed to target the mutations in genes that cause cancer - in an effort to attack the cancer with minimal side effects. Oftentimes, patients develop resistance to drugs and new therapeutic strategies must be applied, so physicians use a second line drug, or combination of drugs, in an effort to target the new gene mutations that develop. Knowing exactly when this mutation and subsequent resistance occurs may be very helpful in identifying when new therapies may be prescribed.

In this study, researchers worked with eight leukemia patients who had participated in a clinical trial involving a compound known as AC220, the first clinically-active FLT3 inhibitor. All eight patients relapsed after first achieving deep remissions with AC220. The relapse indicated that patients had developed a resistance to the drug.

AML is characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells. Treatment includes chemotherapy in order to eliminate leukemic cells and stem cell transplantation. However, through the identification of a valid therapeutic target (FLT3), scientists can begin to develop new and more effective therapies in the future.

"Mount Sinai is deeply committed to addressing the problem of drug resistance in all diseases including cancer and infections with viruses or bacteria," said Kasarskis. "This study certainly tries to address the issue, and will look forward to making continued progress in this area."


'/>"/>
Contact: Mount Sinai Press Office
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. Scientists complete first-ever emperor penguin count from space
2. Scientists count penguins from space
3. Researchers use game to change how scientists study disease outbreaks
4. Salk scientists redraw the blueprint of the bodys biological clock
5. Scientists study the catalytic reactions used by plants to split oxygen from water
6. Scripps Research Institute scientists find promising vaccine targets on hepatitis C virus
7. Dartmouth scientists track radioactive iodine from Japan nuclear reactor meltdown
8. Genetic mutation depicted in van Goghs sunflower paintings revealed by scientists
9. UGA scientists reveal genetic mutation depicted in van Goghs sunflower paintings
10. Scientists win $2 million to study new pathway in development and maintenance of lymphoma
11. WileyChina.com - Now Featuring Bespoke Pages for China’s Life Scientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 2014 /PRNewswire-iReach/ -- The Geneva Healthcare Suite, an innovative ... cut emergency room wait times by an average of ... Center, according to a recent study published in the ... using the suite to access data from incoming patients, ... "Using Geneva,s technology platform we have been able ...
(Date:7/24/2014)... native animal species for food or commercial food sale, ... in the decline of many species of primates and ... more than half of the species being consumed are ... surveying not only the meat made available for sale ... forest by hunters and brought to villages for consumption, ...
(Date:7/24/2014)... Acoustic disturbance has different effects on different species ... the Universities of Bristol and Exeter which tested ... sooner to a flying seagull predator model when ... observed in European minnows. , Lead author ... Sciences said: "Noise levels in many aquatic environments ...
Breaking Biology News(10 mins):UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite 2UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite 3
... commercially prized fish from the depths of the world's ... ability to recover is constrained by the fishes' long ... said today at the annual meeting of the American ... fish species living at depths greater than 500 meters ...
... way to fight leukemia might be to knock out a ... study shows. , The findings suggest that a drug ... be an effective therapy. , But such a ... offer an effective one-two punch against drug-resistant forms of chronic ...
... Uganda who self-paid for their antiretroviral medications experienced interruptions ... supply logistical disruptions. These treatment interruptions led to ... , These findings by a team led by researchers ... and UCSF are reported in the April 22, 2007 ...
Cached Biology News:Long-lived deep-sea fishes imperiled by technology, overfishing 2Long-lived deep-sea fishes imperiled by technology, overfishing 3Knocking out survival protein could aid leukemia treatment 2Resistance to anti-HIV drugs in Uganda developed due to drug supply problems 2
(Date:7/25/2014)... Diego, CA (PRWEB) July 25, 2014 WABC ... For Your Pet with Lorry Young will be hosting ... to talk about stem cell therapy in pets. Dr. ... the benefits of stem cell therapy for pets suffering from ... moving the Regenerative Veterinary Medicine industry forward. , Young has ...
(Date:7/25/2014)... Lawrence Livermore scientists Charles Westbrook and William ... " The World's Most Influential Scientific Minds ." , ... who were identified by analyzing citation data over the ... highest-impact work (2002-2012 and 2012-2013). The two were selected ... . , "This recognition is a great honor for ...
(Date:7/25/2014)... Pa. , July 25, 2014 /PRNewswire-iReach/ -- ... and consulting for global corporations operating in highly ... host its first annual Global User Group Conference, ... historic Philadelphia, Pennsylvania at ... - http://photos.prnewswire.com/prnh/20140724/130263 This ...
(Date:7/25/2014)... , July 25, 2014 Sinovac Biotech Ltd. (Nasdaq: ... in China , today announced that it ... ended June 30, 2014, after market close on Thursday, August ... prior to the market opening on Friday, August 15, 2014, ... p.m. China Standard Time) to review the Company,s financial results ...
Breaking Biology Technology:Robert J. Harman, DVM, Founder and CEO of Vet-Stem, Inc. to Join New York Radio Host Lorry Young in Upcoming Episode of A “Paws” For Your Pet 2Robert J. Harman, DVM, Founder and CEO of Vet-Stem, Inc. to Join New York Radio Host Lorry Young in Upcoming Episode of A “Paws” For Your Pet 3Scientists Burst onto Influential List for Combustion Research 2Scientists Burst onto Influential List for Combustion Research 3Scientists Burst onto Influential List for Combustion Research 4Xybion Announces It Will Host International User Conference in Philadelphia 2Xybion Announces It Will Host International User Conference in Philadelphia 3Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results 2
... July 1 Encorium Group, Inc. (Nasdaq: ... research organization (CRO) that provides design, development, and management ... of the world,s leading pharmaceutical companies, today provided an ... letter of intent with Pierrel SpA, an international contract ...
... ROCKVILLE, Maryland, July 1 Human Genome Sciences, Inc. (Nasdaq: ... have top-line results available on Monday, July 20, from BLISS-52, ... BENLYSTA(TM) (belimumab, formerly LymphoStat-B(R)) in systemic lupus erythematosus (SLE). ... ) , , Senior management will host ...
... international team of researchers has modified chlorophyll from an alga ... bacteria. The team was then able to determine the structure ... converting sunlight into energy using an artificial leaf. The researchers ... the online Early Edition of the PNAS journal ...
Cached Biology Technology:Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business 2Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business 3Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business 4Human Genome Sciences to Host July 20 Conference Call to Discuss Top-Line Phase 3 Results for Benlysta(TM) (Formerly Lymphostat-B(R)) in Systemic Lupus Erythematosus 2First step to converting solar energy using 'artificial leaf' 2